NO20062661L - Beta-laktamer for behandling av CNS lidelser - Google Patents
Beta-laktamer for behandling av CNS lidelserInfo
- Publication number
- NO20062661L NO20062661L NO20062661A NO20062661A NO20062661L NO 20062661 L NO20062661 L NO 20062661L NO 20062661 A NO20062661 A NO 20062661A NO 20062661 A NO20062661 A NO 20062661A NO 20062661 L NO20062661 L NO 20062661L
- Authority
- NO
- Norway
- Prior art keywords
- cyano
- hydroxy
- halogen
- alkyl
- represents hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0326407.4A GB0326407D0 (en) | 2003-11-12 | 2003-11-12 | Chemical compounds |
| PCT/EP2004/012772 WO2005049600A1 (en) | 2003-11-12 | 2004-11-10 | Beta-lactams for treatment of cns disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20062661L true NO20062661L (no) | 2006-06-09 |
Family
ID=29726427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20062661A NO20062661L (no) | 2003-11-12 | 2006-06-09 | Beta-laktamer for behandling av CNS lidelser |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20080262041A1 (ru) |
| EP (1) | EP1689737B1 (ru) |
| JP (1) | JP2007510692A (ru) |
| KR (1) | KR20060118477A (ru) |
| CN (1) | CN1878764A (ru) |
| AR (1) | AR046233A1 (ru) |
| AT (1) | ATE401321T1 (ru) |
| AU (1) | AU2004291296B2 (ru) |
| BR (1) | BRPI0416285A (ru) |
| CA (1) | CA2546007A1 (ru) |
| CY (1) | CY1108404T1 (ru) |
| DE (1) | DE602004015144D1 (ru) |
| DK (1) | DK1689737T3 (ru) |
| ES (1) | ES2310295T3 (ru) |
| GB (1) | GB0326407D0 (ru) |
| HK (1) | HK1094698A1 (ru) |
| HR (1) | HRP20080501T3 (ru) |
| IL (1) | IL175279A0 (ru) |
| IS (1) | IS8477A (ru) |
| MA (1) | MA28156A1 (ru) |
| MY (1) | MY138378A (ru) |
| NO (1) | NO20062661L (ru) |
| PL (1) | PL1689737T3 (ru) |
| PT (1) | PT1689737E (ru) |
| RU (1) | RU2006120417A (ru) |
| SI (1) | SI1689737T1 (ru) |
| TW (1) | TW200528439A (ru) |
| WO (1) | WO2005049600A1 (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101410372A (zh) | 2006-01-24 | 2009-04-15 | 拜欧希格诺有限公司 | 新内酰胺类 |
| AU2015200142B2 (en) * | 2006-01-24 | 2016-07-07 | Unilever Plc | Novel lactams |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL262366A (ru) * | 1960-03-14 | |||
| FR2676055B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| CA2083891A1 (en) * | 1991-12-03 | 1993-06-04 | Angus Murray Macleod | Heterocyclic compounds, compositions containing them and their use in therapy |
| GB9200535D0 (en) * | 1992-01-10 | 1992-02-26 | Fujisawa Pharmaceutical Co | New compound |
| US5824690A (en) * | 1993-05-06 | 1998-10-20 | Hoechst Marion Roussel Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines |
| GB9317104D0 (en) * | 1993-08-17 | 1993-09-29 | Zeneca Ltd | Therapeutic heterocycles |
| GB9322643D0 (en) * | 1993-11-03 | 1993-12-22 | Zeneca Ltd | Lactam derivatives |
| ATE177095T1 (de) * | 1994-08-25 | 1999-03-15 | Merrell Pharma Inc | Substituierte piperidine für die behandlung von allergischen krankheiten |
| US5780466A (en) * | 1995-01-30 | 1998-07-14 | Sanofi | Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present |
| TW332201B (en) * | 1995-04-06 | 1998-05-21 | Janssen Pharmaceutica Nv | 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives |
| US6211199B1 (en) * | 1995-11-17 | 2001-04-03 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| FR2779429B1 (fr) * | 1998-06-03 | 2000-07-13 | Synthelabo | Derives d'oxindole, leurs preparations et leurs applications en therapeutique |
| US6204265B1 (en) * | 1998-12-23 | 2001-03-20 | Schering Corporation | Substituted oximes and hydrazones as neurokinin antagonists |
| GB0114867D0 (en) * | 2001-06-18 | 2001-08-08 | Merck Sharp & Dohme | Therapeutic agents |
| GB0412865D0 (en) * | 2004-06-09 | 2004-07-14 | Glaxo Group Ltd | Chemical compounds |
-
2003
- 2003-11-12 GB GBGB0326407.4A patent/GB0326407D0/en not_active Ceased
-
2004
- 2004-11-10 AT AT04797809T patent/ATE401321T1/de active
- 2004-11-10 CA CA002546007A patent/CA2546007A1/en not_active Abandoned
- 2004-11-10 KR KR1020067009274A patent/KR20060118477A/ko active IP Right Grant
- 2004-11-10 WO PCT/EP2004/012772 patent/WO2005049600A1/en active IP Right Grant
- 2004-11-10 PL PL04797809T patent/PL1689737T3/pl unknown
- 2004-11-10 MY MYPI20044708A patent/MY138378A/en unknown
- 2004-11-10 CN CNA2004800333979A patent/CN1878764A/zh active Pending
- 2004-11-10 SI SI200430872T patent/SI1689737T1/sl unknown
- 2004-11-10 TW TW093134192A patent/TW200528439A/zh unknown
- 2004-11-10 AU AU2004291296A patent/AU2004291296B2/en not_active Ceased
- 2004-11-10 BR BRPI0416285-4A patent/BRPI0416285A/pt not_active IP Right Cessation
- 2004-11-10 AR ARP040104145A patent/AR046233A1/es not_active Application Discontinuation
- 2004-11-10 ES ES04797809T patent/ES2310295T3/es active Active
- 2004-11-10 RU RU2006120417/04A patent/RU2006120417A/ru not_active Application Discontinuation
- 2004-11-10 DE DE602004015144T patent/DE602004015144D1/de active Active
- 2004-11-10 EP EP04797809A patent/EP1689737B1/en active Active
- 2004-11-10 US US10/595,662 patent/US20080262041A1/en not_active Abandoned
- 2004-11-10 DK DK04797809T patent/DK1689737T3/da active
- 2004-11-10 JP JP2006538791A patent/JP2007510692A/ja active Pending
- 2004-11-10 PT PT04797809T patent/PT1689737E/pt unknown
-
2006
- 2006-04-27 IL IL175279A patent/IL175279A0/en unknown
- 2006-05-11 MA MA29020A patent/MA28156A1/fr unknown
- 2006-05-22 IS IS8477A patent/IS8477A/is unknown
- 2006-06-09 NO NO20062661A patent/NO20062661L/no not_active Application Discontinuation
-
2007
- 2007-01-24 HK HK07100589A patent/HK1094698A1/xx not_active IP Right Cessation
-
2008
- 2008-10-08 CY CY20081101120T patent/CY1108404T1/el unknown
- 2008-10-09 HR HR20080501T patent/HRP20080501T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2546007A1 (en) | 2005-06-02 |
| DE602004015144D1 (de) | 2008-08-28 |
| BRPI0416285A (pt) | 2007-01-23 |
| AU2004291296A1 (en) | 2005-06-02 |
| JP2007510692A (ja) | 2007-04-26 |
| KR20060118477A (ko) | 2006-11-23 |
| AR046233A1 (es) | 2005-11-30 |
| HK1094698A1 (en) | 2007-04-04 |
| GB0326407D0 (en) | 2003-12-17 |
| AU2004291296B2 (en) | 2011-04-07 |
| MY138378A (en) | 2009-05-29 |
| EP1689737B1 (en) | 2008-07-16 |
| SI1689737T1 (sl) | 2008-12-31 |
| IS8477A (is) | 2006-05-22 |
| TW200528439A (en) | 2005-09-01 |
| IL175279A0 (en) | 2006-09-05 |
| ATE401321T1 (de) | 2008-08-15 |
| CN1878764A (zh) | 2006-12-13 |
| CY1108404T1 (el) | 2014-02-12 |
| PT1689737E (pt) | 2008-10-24 |
| EP1689737A1 (en) | 2006-08-16 |
| DK1689737T3 (da) | 2008-10-27 |
| ES2310295T3 (es) | 2009-01-01 |
| WO2005049600A1 (en) | 2005-06-02 |
| HRP20080501T3 (en) | 2008-11-30 |
| RU2006120417A (ru) | 2007-12-27 |
| US20080262041A1 (en) | 2008-10-23 |
| PL1689737T3 (pl) | 2008-12-31 |
| MA28156A1 (fr) | 2006-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2015341913B2 (en) | Pharmaceutical compound | |
| AU2011297889B2 (en) | Pharmaceutically active compounds as Axl inhibitors | |
| KR101645379B1 (ko) | 선택적 히스톤 탈아세틸화 효소 억제제로서의 신규 화합물 및 이를 포함하는 약제학적 조성물 | |
| PE20231312A1 (es) | Derivados triciclicos de carboxamida como inhibidores de la prmt5 | |
| NO20051051L (no) | Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme i terapeutiske midler | |
| AR049739A1 (es) | Derivados de aril-piridina | |
| JP3981406B2 (ja) | ５−ｈｔ４レセプター拮抗薬 | |
| NO20071140L (no) | Nye piperidinderivater som histamin H3 reseptorligander for behandling av depresjon | |
| AR114070A1 (es) | Inhibidores de glicolato oxidasa para el tratamiento de una enfermedad | |
| EA200401431A1 (ru) | Производные триазола в качестве антагонистов рецептора тахикинина | |
| NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
| BRPI0409110A (pt) | derivados de 4-(4-heterociclilalcoxi)fenil-1-(heterociclil-carboni l)piridina e compostos relacionados como antagonistas de histamina h3 para o tratamento de doenças neurológicas tais como alzheimer | |
| JP6458028B2 (ja) | インドール及びピロールの新規な誘導体、その製造方法及びそれを含む医薬組成物 | |
| ATE480239T1 (de) | Angiogeneseinhibitoren | |
| JP2020512399A (ja) | Ｉｄｏを抑制する化合物、その調製方法及びその使用 | |
| AR087354A1 (es) | Inhibidores selectivos de la proteina quinasa | |
| NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor | |
| NO20063330L (no) | Amidderivater med en syklopropylaminokarbonylsubstituent som er nyttige som cytokininhibitorer | |
| JP2004523475A (ja) | タンパク質Ｊｕｎキナーゼのインヒビターとしての医薬的活性ベンズスルホンアミド誘導体 | |
| DK2139881T3 (da) | Quinoliner og deres terapeutiske anvendelse | |
| DE602004020730D1 (de) | Pharmazeutisches verfahren und damit hergestellte verbindungen | |
| JP2008525398A5 (ru) | ||
| EA200500095A1 (ru) | Производные 4-(7-гало-2-хино(кса-)линилокси)феноксипропионовой кислоты в качестве противоопухолевых средств | |
| AR071619A1 (es) | Compuestos de pirazina fusionados utiles para el tratamiento de enfermedades degenerativas e inflamatorias y composiciones farmaceuticas que los contienen. | |
| NO20062661L (no) | Beta-laktamer for behandling av CNS lidelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |